Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:26 pm Purchase | 13G | UNIQURE N V QURE | Redmile Group LLC | 2,553,325 5.9% | 2,553,325 (New Position) | View |
2020-02-14 4:26 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | Redmile Group LLC | 3,326,493 9.7% | 1,088,886 (+48.66%) | View |
2020-02-14 4:26 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Redmile Group LLC | 3,000,641 11.1% | 587,999 (+24.37%) | View |
2020-02-14 4:25 pm Sale | 13G | ARRAY BIOPHARMA INC ARRY | Redmile Group LLC | 0 0% | -16,459,128 (Position Closed) | View |
2020-02-14 4:25 pm Purchase | 13G | FORTY SEVEN INC FTSV | Redmile Group LLC | 2,770,842 5.9% | 2,770,842 (New Position) | View |
2020-02-14 4:25 pm Purchase | 13G | ALLAKOS INC ALLK | Redmile Group LLC | 3,033,526 6.2% | 3,033,526 (New Position) | View |
2020-02-14 4:25 pm Purchase | 13G | AMICUS THERAPEUTICS INC FOLD | Redmile Group LLC | 25,482,769 9.9% | 15,552,766 (+156.62%) | View |
2020-02-14 4:25 pm Sale | 13G | ATRECA INC BCEL | Redmile Group LLC | 1,136,806 5.2% | -3,500 (-0.31%) | View |
2020-02-14 4:25 pm Sale | 13G | AUDENTES THERAPEUTICS INC BOLD | Redmile Group LLC | 639,095 1.4% | -1,662,572 (-72.23%) | View |
2020-02-14 4:25 pm Sale | 13G | CHIMERIX INC CMRX | Redmile Group LLC | 0 0% | -3,564,950 (Position Closed) | View |
2020-02-14 4:25 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 4,709,498 9.2% | 4,709,498 (New Position) | View |
2020-02-14 4:25 pm Sale | 13G | NIGHTSTAR THERAPEUTICS PLC ADR NITE | Redmile Group LLC | 0 0% | -1,795,846 (Position Closed) | View |
2020-02-14 4:25 pm Sale | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Redmile Group LLC | 0 0% | -2,227,507 (Position Closed) | View |
2020-02-14 4:25 pm Purchase | 13G | REPLIMUNE GROUP INC REPL | Redmile Group LLC | 3,621,635 9.9% | 1,432,679 (+65.45%) | View |
2020-02-14 4:25 pm Sale | 13G | TCR2 THERAPEUTICS INC TCRR | Redmile Group LLC | 1,799,188 7.5% | -8,068 (-0.45%) | View |
2020-02-14 4:25 pm Sale | 13G | XENCOR INC XNCR | Redmile Group LLC | 0 0% | -3,084,703 (Position Closed) | View |
2020-02-14 4:25 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Redmile Group LLC | 3,430,529 5.9% | -630,000 (-15.52%) | View |
2020-02-14 4:25 pm Purchase | 13G | GRITSTONE BIO INC GRTS | Redmile Group LLC | 3,116,594 8.7% | 847,459 (+37.35%) | View |
2020-02-14 4:25 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | Redmile Group LLC | 1,892,521 8.8% | 342 (+0.02%) | View |
2020-02-14 4:25 pm Purchase | 13G | IMMUNOGEN INC IMGN | Redmile Group LLC | 14,639,960 9.8% | 3,755,353 (+34.50%) | View |